British scientist develops technology able to deliver drugs directly into the brain
February 27, 2019Research and Development device, medical technology, neurology, neuroscince, parkinson's cns
A British scientist has developed innovative technology that is able to deliver drugs deep into the brain in order to …
Professor Patrick Chinnery named as Clinical Director of MRC
February 26, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Professor Patrick Chinnery has been appointed to the role of Clinical Director at the Medical Research Council (MRC) the non-departmental …
Read the March 2019 issue of Pharmafocus online now!
February 26, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Drug pricing, HIV, Trump, WHO, brexit, depression, mental health, pharmacovigilance, rare disease
Just one month to go until Brexit here in the UK, and it’s still all to play for. After months …
Jury upholds Amgen’s patent validity for Repatha, deflecting challenge from Sanofi and Regeneron
February 26, 2019Manufacturing and Production, Sales and Marketing Amgen, Regeneron, Repatha, Sanofi, patent, pharma
Amgen is celebrating after a Delaware jury backed the validity of two of its patents against challenges from Regeneron and …
Vitamin D deficiency may cause cognitive decline through weakening brain’s scaffolding
February 26, 2019Manufacturing and Production NPP, mental health, neurology, neuroscience, schizophrenia, vitamin d
Vitamin D deficiency may weaken supportive ‘scaffolding’ in the brain thus causing neurons difficulty in maintaining connections, according to a …
Lynparza extends progression-free survival in gBRCAm metastatic pancreatic cancer
February 26, 2019Manufacturing and Production, Sales and Marketing AstraZeneca, Cancer, MSD, Pancreatic cancer, lynparza, pharma
AstraZeneca and MSD have lifted the curtain on new Phase 3 data for Lynparza (olaparib), confirming that the drug generated …
Unvaccinated French boy blamed for reintroducing measles to Costa Rica
February 26, 2019Manufacturing and Production Costa Rica, France, WHO, vaccine hesitancy, vaccines
A French boy is suspected of reintroducing measles to Costa Rica after the country has been free of the infectious …
Rise in populism linked to vaccine hesitancy in Europe, study shows
February 26, 2019Manufacturing and Production EU, Europe, populism, populist parties, vaccine hesitancy, vaccines
Parent’s reluctance to vaccinate their children correlates with the number of people voting for populist parties, according to a study …
Living with melanoma after surgery
February 25, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, melanoma, patient experience, pharma
Dr Elizabeth Walmsley was left lost when she received her melanoma diagnosis. Thankfully, through perseverance and the advice of friends …
Ipsen shells out $1.31bn to acquire rare disease specialist Clementia Pharmaceuticals
February 25, 2019Sales and Marketing Clementia pharmaceuticals, acquisition, ipsen, rare disease
In a bid to boost its rare disease portfolio prospects, Ipsen has revealed its intention to acquire Clementia Pharmaceuticals, with …
UK launches drug testing service for illicit drugs
February 25, 2019Sales and Marketing Home office, UK, cocaine, drugs, fentanyl, illicit substances, recreational drugs
The UK Home Office have licensed a drug-checking service for users of illicit substances. The yearlong pilot project, run by …
Missouri Supreme Court ruling could help J&J in talc cases
February 25, 2019Sales and Marketing Cancer, J&J, JJ, asbestos, baby powder, lawsuits, legal, talc
The Missouri Supreme Court has ruled that the practice of combining two or more cases in order to allow courts …
Roche set to acquire Spark Therapeutics in $4.8 billion deal
February 25, 2019Sales and Marketing Roche, Spark Therapeutics, acquisition, gene therapy, pharma
Roche is set to fully acquire gene therapy Spark Therapeutics after entering into a definitive merger agreement, after the Boards …
Iran ready to export medicines to Venezuela
February 25, 2019Sales and Marketing FDA, Iran, Venezuela, biotech, global, pharma
The chairman of the Iranian Food and Drug Administration (FDA) Mehdi Pirsalehi, has said that Iran is ready to export …
Top Ten most popular articles on Pharmafile.com this week
February 22, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cancer, China, MedImmune, Xeljanz, asthma, diabetes, keytruda, osteoarthritis, pharma, rare disease
Happy Friday! With the weekend within reach, check out our run-down of the top ten most popular articles on Pharmafile.com …
US Department of Justice investigate J&J over Baby Powder allegations
February 22, 2019Medical Communications Cancer, J&J, JJ, Johnson and Johnson, USA, asbestos, oncology, talc
The Justice Department and US Securities and Exchanges Commission are investigation healthcare giant Johnson & Johnson over allegations that Johnson’s …
MHRA warns of congenital malformation risk of neo-mercazole during pregnancy
February 22, 2019Medical Communications, Research and Development MHRA, neo-mercazole, pharma
UK drug watchdog The Medicines and Healthcare products Regulatory Agency (MHRA) has warned of the potential side-effects of Neo-mercazole (carbimazole) …
Genetically modified twins may have been altered in a way that improves memory and cognition
February 22, 2019Medical Communications CCR5, HIV, cognitive enhancement, crispr, gene editing
The twins who were genetically modified using the gene editing tool CRISPR may have been changed in a way that …
Poison control calls for kratom increase from one a month to two a day, study shows
February 22, 2019Medical Communications USA, herbal medicines, kratom, poison control, toxicology
The number of phone calls to US poison control centres over exposures to kratom – an herbal drug with opioid …
FDA halts Xencor’s acute myeloid leukaemia trial following two patient deaths
February 21, 2019Research and Development Cancer, FDA, Xencor, leukaemia, pharma
Cancer biopharma firm Xencor has revealed it is to place a hold on its ongoing Phase 1 trial of XmAb14045, …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
